Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis

Paediatric multidrug-resistant (MDR) tuberculosis is a public health challenge of growing concern, accounting for an estimated 15% of all global cases of MDR tuberculosis. Clinical management is especially challenging, and recommendations are based on restricted evidence. We aimed to assess existing...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Lancet infectious diseases Ročník 12; číslo 6; s. 449 - 456
Hlavní autori:	Ettehad, Dena, Schaaf, H Simon, Seddon, James A, Cooke, Graham S, Ford, Nathan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Elsevier Ltd 01.06.2012 Lancet Publishing Group Elsevier Limited
Predmet:	Antitubercular Agents - adverse effects Antitubercular Agents - therapeutic use Bacterial diseases Biological and medical sciences Child Children Drug resistance Hearing loss Human bacterial diseases Humans Hypothyroidism Infectious Disease Infectious diseases Medical sciences Mycobacterium Nausea Pediatrics Public health Reviews Time Factors Treatment Outcome Tuberculosis Tuberculosis and atypical mycobacterial infections Tuberculosis, Multidrug-Resistant - drug therapy Vomiting Human Infection Prognosis Treatment Tuberculosis Multiple resistance Bacteriosis Mycobacterial infection Child Bibliographic review
ISSN:	1473-3099, 1474-4457, 1474-4457
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!